18525128|t|Value of measuring plasmatic levels of neurosin in the diagnosis of Alzheimer's disease.
18525128|a|The search for molecular biomarkers for diagnosing and classifying dementias is becoming a high priority need. Neurosin (Kallikrein 6, hk6) is one molecule with promising preliminary results since its levels in brain tissue, cerebrospinal fluid and blood have been found to be abnormal in Alzheimer's disease (AD). In this study, we measured plasmatic levels of neurosin in healthy individuals and patients with cognitive symptoms independently of what the final diagnosis was. We collected plasma samples from 228 controls and 447 patients finally diagnosed with either AD, Mild Cognitive Impairment, Dementia with Lewy Bodies or Parkinson-Dementia, Frontotemporal Dementia, Huntington's disease, Primary Progressive Aphasia, Corticobasal degeneration, Creutzfeldt-Jakob's disease or Pseudodementia. We found that plasmatic levels of neurosin increase with age in healthy individuals and decrease in patients with AD. Plasmatic levels of neurosin differ significantly between AD and Vascular Dementia, Pseudodementia and the control group. Analyses comparing any other form of neurodegenerative dementia to the AD group did not show significant differences. In conclusion, measurement of plasmatic levels of neurosin is useful to distinguish AD patients from subjects without neurodegenerative dementia (either Pseudodementia, Vascular Dementia or controls) although it is not useful to distinguish among neurodegenerative dementias.
18525128	39	47	neurosin	Gene	5653
18525128	68	87	Alzheimer's disease	Disease	MESH:D000544
18525128	156	165	dementias	Disease	MESH:D003704
18525128	200	208	Neurosin	Gene	5653
18525128	210	222	Kallikrein 6	Gene	5653
18525128	224	227	hk6	Gene	5653
18525128	378	397	Alzheimer's disease	Disease	MESH:D000544
18525128	399	401	AD	Disease	MESH:D000544
18525128	451	459	neurosin	Gene	5653
18525128	487	495	patients	Species	9606
18525128	501	519	cognitive symptoms	Disease	MESH:D019954
18525128	621	629	patients	Species	9606
18525128	660	662	AD	Disease	MESH:D000544
18525128	669	689	Cognitive Impairment	Disease	MESH:D003072
18525128	691	716	Dementia with Lewy Bodies	Disease	MESH:D020961
18525128	720	738	Parkinson-Dementia	Disease	MESH:C537240
18525128	740	763	Frontotemporal Dementia	Disease	MESH:D057180
18525128	765	785	Huntington's disease	Disease	MESH:D006816
18525128	787	814	Primary Progressive Aphasia	Disease	MESH:D018888
18525128	816	841	Corticobasal degeneration	Disease	MESH:D000088282
18525128	843	870	Creutzfeldt-Jakob's disease	Disease	MESH:D007562
18525128	874	888	Pseudodementia	Disease	MESH:D005162
18525128	924	932	neurosin	Gene	5653
18525128	990	998	patients	Species	9606
18525128	1004	1006	AD	Disease	MESH:D000544
18525128	1028	1036	neurosin	Gene	5653
18525128	1066	1068	AD	Disease	MESH:D000544
18525128	1073	1090	Vascular Dementia	Disease	MESH:D015140
18525128	1092	1106	Pseudodementia	Disease	MESH:D005162
18525128	1167	1193	neurodegenerative dementia	Disease	MESH:D019636
18525128	1201	1203	AD	Disease	MESH:D000544
18525128	1298	1306	neurosin	Gene	5653
18525128	1332	1334	AD	Disease	MESH:D000544
18525128	1335	1343	patients	Species	9606
18525128	1366	1392	neurodegenerative dementia	Disease	MESH:D019636
18525128	1401	1415	Pseudodementia	Disease	MESH:D005162
18525128	1417	1434	Vascular Dementia	Disease	MESH:D015140
18525128	1495	1522	neurodegenerative dementias	Disease	MESH:D019636
18525128	Association	MESH:D005162	5653
18525128	Association	MESH:D015140	5653
18525128	Association	MESH:D000544	5653

